Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: Results of the APrODiTe study

Hypertension Research

Volumn 37, Issue 2, 2014, Pages 172-178

  Cha, Ran Hui ^a   Kim, Sejoong ^b   Yoon, Sun Ae ^c   Ryu, Dong Ryeol ^d   Oh, Ji Eun ^e   Han, Sang Youb ^f   Lee, Eun Young ^g   Kim, Dong Ki ^h   Kim, Yon Su ^h  

^a National Medical Center   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Hallym University   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

Author keywords

ambulatory blood pressure monitoring; blood pressure; chronic kidney disease; target organ damage

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KOREA; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MIDDLE AGED; OBESITY; ORGAN INJURY; PROTEINURIA; SEX DIFFERENCE; STABLE ANGINA PECTORIS; TARGET PRGAN DAMAGE; WHITE COAT HYPERTENSION; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; ANTHROPOMETRY; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 84893720746     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.127     Document Type: Article

References (41)

1. Mancia G, Backer GD, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM. 2007 guidelines for the management of arterial hypertensionThe task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart 2007; 28: 1462-1536.
2. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
3. Hansoon L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. HOT Study Group. Lancet 1998; 35: 1755-1762.
4. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153.
5. Bakris GL, Wiliams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661.
6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
7. Lee SW, Kim YC, Oh SW, Koo HS, Na KY, Chad DW, Kim S, Chin HJ. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korea National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011; 26: 3975-3980.
8. Seo MH, Lee WJ, Park CY, Kim SR, Park JY, Yoon KH, Lee MK, Park SW. Management of blood pressure in patients with type 2 diabetes mellitus: a nationwide survey in Korean. Diabetes Metab J 2011; 35: 348-353.
9. Terawaki H, Metoki H, Nakayama M, Ohukubo T, Kikuya M, Asayama K, Inoue R, Hoshi H, Ito S, Imai Y. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res 2008; 31: 2129-2135.
10. Portaluppi F, Montanari L, Massari M, Chiara VD, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens 1991; 4: 20-26.
11. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797-805.
12. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. 'Non-dipper' hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995; 43: 382-387.
13. Thomson AM, Pickering TG. The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int 2006; 70: 1000-1007.
14. Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 2005; 46: 514-520.
15. Liu M, Takahashi H, Morita Y, Maruyama S, Mizuno M, Yuzawa Y, Watanabe M, Toriyama T, Kawahara H, Matsuo S. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 563-569.
16. Song HC, Choi EJ, Park IS, Ahn SJ, Jin DC, Kin SY, Koo WS, Chang YS, Bang BK. Impaired circadian rhythm of blood pressure in various stage of renal failure. Korean J Nephrol 1995; 4: 310-316.
17. Buchner S, Debl K, Haimerl J, Djavidani B, Poschenrieder F, Feuerbach S, Riegger GA, Luchner A. Electrocardiographic diagnosis of left ventricular hypertrophy in aortic valve disease: evaluation of ECG criteria by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2009; 1: 11-18.
18. Morrison I, Clark E, Macfarlane PW. Evaluation of the electrocardiographic criteria for left ventricular hypertrophy. Anadolu Kardiyol Derg 2007; 7: 159-163.
19. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis. J Hypertens 1996; 14: 557-563.
20. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida Afor the Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephol 2013; 8: 721-730.
21. Wang C, Zhang J, Liu X, Li C, Ye Z, Peng H, Chen Z, Lou T. Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease. PLoS One 2013; 8: e55419.
22. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Philips RAAfrican American Study of Kidney Disease and Hypertension Collaborative Research Group. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 2009; 53: 20-27.
23. Li X, Li Y, Jia N, Guo S, Chu S, Niu W. Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis. Mol Biol Rep 2012; 39: 10063-10075.
24. Sethi AA, Nordestgaard BG, Tybjærg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269-1275.
25. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PHDASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
26. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol 2009; 4: 656-664.
27. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsama F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321-1328.
28. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, Era S. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004; 66: 1988-1993.
29. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006; 48: 527-533.
30. Jensen LW, Pedersen EB. Nocturnal blood pressure and relation to vasoactive hormones and renal function in hypertension and chronic renal failure. Blood Press 1997; 6: 332-342.
31. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997; 96: 1173-1179.
32. Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Maeda A, Dejima T, Wakui H, Ozawa M, Shigenaga A, Toya Y, Umemura S. Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease. Am J Cardiovasc Dis 2011; 1: 236-243.
33. Fujii T, Uzu T, Nishimura M, Takaji M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999; 33: 29-35.
34. Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859-1862.
35. Wilson DK, Sica DA, Miller SB. Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents. Hypertension 1999; 34: 181-186.
36. Hermida RC, Ayala DE, Fernández JR, Calvo C. Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension. Hypertension 2008; 51: 69-76.
37. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, Mojón A, López JE. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42: 283-290.
38. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995; 8: 719-726.
39. Hermida RC, Calvo C, Ayala DE, López JE. Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 2005; 46: 960-968.
40. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, Yoshida A, Kimura G. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65: 621-625.
41. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005; 45: 994-1001.